One example of this is the identification of mutations in isocitrate dehydrogenase 1 (IDH1) and/or 2 (IDH2) as critical biomarkers for glioma classification and prognosis (Weller et al., 2015). The gene discussed is IDH1; the disease is central nervous system cancer.